Delfini Lisa
Insider CIK 1873253 · TRVI Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-05-31 | 2025-06-03 | 72,000 | — | $0 | 110,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-12 | 38,400 | — | $0 | 38,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 225,500 | — | $0 | 225,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-01-08 | 2025-01-10 | 5,000 | — | $0 | 42,125 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-01-08 | 2025-01-10 | 5,000 | $0.51 | $2.5K | 64,660 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-01-07 | 2025-01-10 | 1,000 | — | $0 | 47,125 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-01-07 | 2025-01-10 | 1,000 | $0.51 | $510 | 59,660 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-05-22 | 2024-05-24 | 16,043 | — | $0 | 48,125 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-05-22 | 2024-05-24 | 4,350 | $2.64 | $11.5K | 53,279 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-05-22 | 2024-05-24 | 16,043 | $0.51 | $8.2K | 57,629 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 175,000 | — | $0 | 175,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-10-11 | 2023-10-12 | 2,292 | — | $0 | 64,168 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-10-11 | 2023-10-12 | 2,292 | $0.51 | $1.2K | 36,686 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-10-11 | 2023-10-12 | 785 | $2.02 | $1.6K | 35,901 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-09-11 | 2023-09-13 | 2,291 | — | $0 | 66,460 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-09-11 | 2023-09-13 | 711 | $2.20 | $1.6K | 34,394 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-09-11 | 2023-09-13 | 2,291 | $0.51 | $1.2K | 35,105 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-08-11 | 2023-08-14 | 2,292 | — | $0 | 68,751 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-08-11 | 2023-08-14 | 682 | $2.36 | $1.6K | 32,814 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-08-11 | 2023-08-14 | 2,292 | $0.51 | $1.2K | 33,496 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-07-11 | 2023-07-12 | 2,292 | — | $0 | 71,043 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-07-11 | 2023-07-12 | 2,292 | $0.51 | $1.2K | 31,891 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-07-11 | 2023-07-12 | 687 | $2.34 | $1.6K | 31,204 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-06-12 | 2023-06-14 | 2,291 | — | $0 | 73,335 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-06-12 | 2023-06-14 | 610 | $2.64 | $1.6K | 29,599 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-06-12 | 2023-06-14 | 2,291 | $0.51 | $1.2K | 30,209 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-05-11 | 2023-05-15 | 2,291 | — | $0 | 75,626 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-05-11 | 2023-05-15 | 2,291 | $0.51 | $1.2K | 28,480 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 562 | $2.89 | $1.6K | 27,918 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-04-11 | 2023-04-12 | 2,292 | — | $0 | 77,917 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-04-11 | 2023-04-12 | 2,292 | $0.51 | $1.2K | 27,029 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-04-11 | 2023-04-12 | 840 | $1.84 | $1.5K | 26,189 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-03-13 | 2023-03-15 | 2,291 | — | $0 | 80,209 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-03-13 | 2023-03-15 | 892 | $1.75 | $1.6K | 24,737 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-03-13 | 2023-03-15 | 2,291 | $0.51 | $1.2K | 25,629 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-16 | 187,500 | — | $0 | 187,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-02-13 | 2023-02-15 | 27,500 | — | $0 | 82,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2023-02-13 | 2023-02-15 | 8,474 | $2.45 | $20.8K | 23,338 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-02-13 | 2023-02-15 | 27,500 | $0.51 | $14.0K | 31,812 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 110,000 | — | $0 | 110,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-08-09 | 2021-08-09 | 100,000 | — | $0 | 100,000 | SEC↗ |